Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein BWilliam R Wikoff, Samir Hanash, Brian DeFelice, et al.Journal for Immunotherapy of Cancer|March 19, 2021
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxelDavid Gandara, Martin Reck, Denis Moro-Sibilot, et al.JCO Precision Oncology|January 7, 2022
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With ChemotherapyWei Zou, Stephanie J Yaung, Frederike Fuhlbrück, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 28, 2016
Serum Glycans as Risk Markers for Non-Small Cell Lung CancerL Renee Ruhaak, Carol Stroble, Jianliang Dai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trialKatherine M W Pisters, Eric Vallières, John J Crowley, et al.European Journal of Cancer (Oxford, England : 1990)|March 21, 2024
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendationsDaniel L Hertz, Markus Joerger, Yung-Jue Bang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)Valerie W Rusch, Dorothy J Giroux, Michael J Kraut, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancerMing-Sound Tsao, Akira Sakurada, Keyue Ding, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor KineticsLaurent Claret, Jin Y Jin, Charles Ferté, et al.Clinical Lung Cancer|July 19, 2016
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin AmericaLuis E Raez, Edgardo S Santos, Christian Rolfo, et al.Pageof 8